AU4448597A - Treatment of cancer using a recombinant poxvirus containing nucleic acid sequence encoding a cytokine - Google Patents

Treatment of cancer using a recombinant poxvirus containing nucleic acid sequence encoding a cytokine

Info

Publication number
AU4448597A
AU4448597A AU44485/97A AU4448597A AU4448597A AU 4448597 A AU4448597 A AU 4448597A AU 44485/97 A AU44485/97 A AU 44485/97A AU 4448597 A AU4448597 A AU 4448597A AU 4448597 A AU4448597 A AU 4448597A
Authority
AU
Australia
Prior art keywords
cytokine
cancer
treatment
nucleic acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44485/97A
Inventor
J. Alexander
M. C. Bonnet
B. Cornet
William Cox
I. Diaz
Diane M Gajewczyk
Michel H. Klein
E. Paoletti
James Tartaglia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Virogenetics Corp
Original Assignee
Connaught Laboratories Ltd
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd, Virogenetics Corp filed Critical Connaught Laboratories Ltd
Publication of AU4448597A publication Critical patent/AU4448597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU44485/97A 1996-10-04 1997-10-03 Treatment of cancer using a recombinant poxvirus containing nucleic acid sequence encoding a cytokine Abandoned AU4448597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2753096P 1996-10-04 1996-10-04
US60027530 1996-10-04
PCT/CA1997/000729 WO1998015635A2 (en) 1996-10-04 1997-10-03 Treatment of cancer using a recombinant poxvirus containing a nucleic acid sequence encoding a cytokine

Publications (1)

Publication Number Publication Date
AU4448597A true AU4448597A (en) 1998-05-05

Family

ID=21838268

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44485/97A Abandoned AU4448597A (en) 1996-10-04 1997-10-03 Treatment of cancer using a recombinant poxvirus containing nucleic acid sequence encoding a cytokine

Country Status (2)

Country Link
AU (1) AU4448597A (en)
WO (1) WO1998015635A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002522009A (en) 1998-04-14 2002-07-23 スージェン・インコーポレーテッド STE-20-related protein kinase
WO2001095919A2 (en) * 2000-06-15 2001-12-20 The Governement Of The United States Of America, As Represented By The Secretary Departement Of Hea Lth And Human Services A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence

Also Published As

Publication number Publication date
WO1998015635A3 (en) 1998-07-09
WO1998015635A2 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
AU584608B2 (en) DNA encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
AU4787697A (en) Therapeutic gene
AU7398194A (en) Oligonucleotide modulation of protein kinase c
AU5355790A (en) Multifunctional m-csf proteins and genes encoding therefor
AU8400398A (en) Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use
AU4844893A (en) Peptide sequencing using mass spectrometry
AU5283793A (en) Recombinant specific binding protein
AU2179197A (en) Novel phytase and gene encoding said phytase
AU5264498A (en) Genes encoding telomerase proteins
AU1376688A (en) Recombinant avipoxvirus
AU3737297A (en) Bacteriophage-mediated gene therapy
AU2222888A (en) Recombinant avipoxvirus
AU580456B2 (en) Bone disorder treatment
AU6655894A (en) Phenylalanine-free protein and dna coding therefor
AU2787692A (en) Method of sequencing double stranded dna
AU7689696A (en) Dna sequence encoding the tumor suppressor ing1
AU588862B2 (en) Human tumor therapy
AU4469696A (en) Nucleic acid encoding a transiently-expressed kinetochore protein, and methods of use
AU6282896A (en) Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
AU6094696A (en) Lead binding polypeptides and nucleotides coding therefor
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU7072896A (en) Dna encoding medicinal proteins
AU2690595A (en) Isolated dna encoding c-(mer) protooncogene
AU6566886A (en) Improved bone stapler
AU4448597A (en) Treatment of cancer using a recombinant poxvirus containing nucleic acid sequence encoding a cytokine